Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
APOLLOHOSP.NS Stock Summary
Top 10 Correlated ETFs
APOLLOHOSP.NS
In the News
APOLLOHOSP.NS Financial details
Company Rating
Buy
Market Cap
916.76B
Income
7.89B
Revenue
184.18B
Book val./share
-
Cash/share
-
Dividend
15
Dividend %
0.26%
Employees
83.15K
Optionable
No
Shortable
Yes
Earnings
28 May 2024
P/E
119.59
Forward P/E
59.73
PEG
-47.44
P/S
4.68
P/B
12.82
P/C
-
P/FCF
793
Quick Ratio
1.09
Current Ratio
1.29
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
54.91
EPS next Y
106.4
EPS next Q
21.56
EPS this Y
-22.41%
EPS next Y
93.78%
EPS next 5Y
193.75%
EPS last 5Y
27.41%
Revenue last 5Y
11.61%
Revenue Q/Q
0.08%
EPS Q/Q
5.31%
-
-
-
-
SMA20
-5.92%
SMA50
6.1%
SMA100
25.87%
Inst Own
-
Inst Trans
-
ROA
4%
ROE
11%
ROC
0.13%
Gross Margin
49%
Oper. Margin
9%
Profit Margin
4%
Payout
-
Shs Outstand
143.79M
Shs Float
98.86M
-
-
-
-
Target Price
-
52W Range
4168.0-6874.45
52W High
-7.55%
52W Low
+52.47%
RSI
55.84
Rel Volume
0.63
Avg Volume
466.74K
Volume
294.82K
Perf Week
3.56%
Perf Month
-5.91%
Perf Quarter
25.59%
Perf Half Y
24.68%
-
-
-
-
Beta
0.552
-
-
Volatility
93.73%, 267.26%
Prev Close
1.98%
Price
6354.95
Change
-0%
APOLLOHOSP.NS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 689.59 | 802.98 | 747.75 | 1.01K | 1.16K | |
Net income per share | 16.97 | 32.7 | 10.74 | 73.42 | 56.97 | |
Operating cash flow per share | 65.05 | 92.92 | 90.96 | 113.22 | 95.77 | |
Free cash flow per share | 16.25 | 56.05 | 69.85 | 67.52 | 17.28 | |
Cash per share | 25.52 | 46.25 | 101.65 | 75.41 | 84.45 | |
Book value per share | 239.6 | 240.01 | 328.77 | 391.09 | 431 | |
Tangible book value per share | 221.93 | 220.59 | 310.11 | 337.07 | 378.31 | |
Share holders equity per share | 239.6 | 240.01 | 328.77 | 391.09 | 431 | |
Interest debt per share | 284.4 | 437.3 | 326.12 | 305.91 | 327.79 | |
Market cap | 176.62B | 158.47B | 406.35B | 649.35B | 619.84B | |
Enterprise value | 210.49B | 210.87B | 443.7B | 684.2B | 658.83B | |
P/E ratio | 74.82 | 34.84 | 270.18 | 61.51 | 75.67 | |
Price to sales ratio | 1.84 | 1.42 | 3.88 | 4.47 | 3.73 | |
POCF ratio | 19.52 | 12.26 | 31.91 | 39.89 | 45.01 | |
PFCF ratio | 78.14 | 20.32 | 41.55 | 66.89 | 249.4 | |
P/B Ratio | 5.3 | 4.75 | 8.83 | 11.55 | 10 | |
PTB ratio | 5.3 | 4.75 | 8.83 | 11.55 | 10 | |
EV to sales | 2.19 | 1.89 | 4.24 | 4.71 | 3.97 | |
Enterprise value over EBITDA | 19.25 | 13.65 | 39.16 | 31.2 | 31.42 | |
EV to operating cash flow | 23.26 | 16.31 | 34.84 | 42.03 | 47.84 | |
EV to free cash flow | 93.13 | 27.04 | 45.37 | 70.48 | 265.09 | |
Earnings yield | 0.01 | 0.03 | 0 | 0.02 | 0.01 | |
Free cash flow yield | 0.01 | 0.05 | 0.02 | 0.01 | 0 | |
Debt to equity | 1.1 | 1.68 | 0.9 | 0.72 | 0.7 | |
Debt to assets | 0.4 | 0.5 | 0.36 | 0.31 | 0.3 | |
Net debt to EBITDA | 3.1 | 3.39 | 3.3 | 1.59 | 1.86 | |
Current ratio | 1.17 | 1.13 | 1.79 | 1.73 | 1.3 | |
Interest coverage | 2.38 | 2.1 | 1.4 | 4.81 | 3.81 | |
Income quality | 4.52 | 2.99 | 9.31 | 1.47 | 1.63 | |
Dividend Yield | 0 | 0.01 | 0 | 0 | 0 | |
Payout ratio | 0.35 | 0.34 | 0.25 | 0.04 | 0.31 | |
Sales general and administrative to revenue | 0.08 | 0.07 | 0.07 | 0.08 | 0.09 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.04 | 0.04 | 0.04 | 0.08 | 0.08 | |
Capex to operating cash flow | -0.75 | -0.4 | -0.23 | -0.4 | -0.82 | |
Capex to revenue | -0.07 | -0.05 | -0.03 | -0.05 | -0.07 | |
Capex to depreciation | -1.72 | -0.83 | -0.52 | -1.09 | -1.83 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 302.44 | 420.2 | 281.91 | 803.76 | 743.26 | |
ROIC | 0.05 | 0.06 | 0.03 | 0.1 | 0.09 | |
Return on tangible assets | 0.03 | 0.04 | 0.01 | 0.09 | 0.06 | |
Graham Net | -292.56 | -433.48 | -265.64 | -282.4 | -326.63 | |
Working capital | 3.26B | 3.1B | 16.04B | 17.38B | 10.12B | |
Tangible asset value | 30.88B | 30.69B | 43.41B | 48.47B | 54.4B | |
Net current asset value | -34.32B | -52.22B | -29.73B | -31.93B | -35.59B | |
Invested capital | 1.1 | 1.68 | 0.9 | 0.72 | 0.7 | |
Average receivables | 13.09B | 12.15B | 14.49B | 22.01B | 24.96B | |
Average payables | 6.51B | 8.11B | 10.34B | 13.96B | 17.74B | |
Average inventory | 5.75B | 6.61B | 4.94B | 3.41B | 4.11B | |
Days sales outstanding | 50.55 | 35.96 | 62.66 | 65.42 | 52.46 | |
Days payables outstanding | 55.85 | 60.32 | 74.49 | 78.64 | 81.55 | |
Days of inventory on hand | 45.8 | 48.97 | 16.02 | 20.82 | 16.61 | |
Receivables turnover | 7.22 | 10.15 | 5.83 | 5.58 | 6.96 | |
Payables turnover | 6.54 | 6.05 | 4.9 | 4.64 | 4.48 | |
Inventory turnover | 7.97 | 7.45 | 22.78 | 17.54 | 21.97 | |
ROE | 0.07 | 0.14 | 0.03 | 0.19 | 0.13 | |
Capex per share | -48.8 | -36.87 | -21.11 | -45.71 | -78.49 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q3
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 296.53 | 299.29 | 307.34 | 337.14 | 337.35 | |
Net income per share | 10.68 | 10.06 | 11.59 | 16.2 | 17.06 | |
Operating cash flow per share | 21.34 | 5.29 | 2.03 | 22.73 | 23.23 | |
Free cash flow per share | 21.34 | 5.29 | 2.03 | 22.73 | 23.23 | |
Cash per share | 0 | 84.47 | 0 | 108.64 | 0 | |
Book value per share | 0 | 431.11 | 0 | 452.72 | 0 | |
Tangible book value per share | 0 | 378.41 | 0 | 400.6 | 0 | |
Share holders equity per share | 0 | 431.11 | 0 | 452.72 | 0 | |
Interest debt per share | 6.95 | 308.02 | 7.39 | 347.8 | 7.83 | |
Market cap | 643.81B | 619.69B | 732.84B | 738.63B | 826.77B | |
Enterprise value | 643.81B | 658.68B | 732.84B | 782.8B | 826.77B | |
P/E ratio | 104.86 | 107.18 | 109.97 | 79.29 | 84.26 | |
Price to sales ratio | 15.1 | 14.4 | 16.59 | 15.24 | 17.04 | |
POCF ratio | 209.86 | 815.38 | 2.51K | 226.02 | 247.54 | |
PFCF ratio | 209.86 | 815.38 | 2.51K | 226.02 | 247.54 | |
P/B Ratio | 0 | 10 | 0 | 11.35 | 0 | |
PTB ratio | 0 | 10 | 0 | 11.35 | 0 | |
EV to sales | 15.1 | 15.31 | 16.59 | 16.15 | 17.04 | |
Enterprise value over EBITDA | 124.01 | 129.64 | 134.94 | 120.1 | 128.6 | |
EV to operating cash flow | 209.86 | 866.68 | 2.51K | 239.53 | 247.54 | |
EV to free cash flow | 209.86 | 866.68 | 2.51K | 239.53 | 247.54 | |
Earnings yield | 0 | 0 | 0 | 0 | 0 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0 | 0.7 | 0 | 0.75 | 0 | |
Debt to assets | 0 | 0.3 | 0 | 0.31 | 0 | |
Net debt to EBITDA | 0 | 7.67 | 0 | 6.78 | 0 | |
Current ratio | 0 | 1.3 | 0 | 1.29 | 0 | |
Interest coverage | 3.66 | 3.66 | 3.22 | 4.39 | 4.23 | |
Income quality | 2 | 0.53 | 0.18 | 1.4 | 1.36 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0.08 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0.08 | 0 | 0.07 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0.02 | 0.01 | 0 | 0 | |
Graham number | 0 | 312.31 | 0 | 406.22 | 0 | |
ROIC | 0 | 0.02 | 0 | 0.02 | 0 | |
Return on tangible assets | 0 | 0.01 | 0 | 0.02 | 0 | |
Graham Net | 0 | -326.71 | 0 | -347.31 | 0 | |
Working capital | 0 | 10.12B | 0 | 11.08B | 0 | |
Tangible asset value | 0 | 54.4B | 0 | 57.59B | 0 | |
Net current asset value | 0 | -35.59B | 0 | -37.96B | 0 | |
Invested capital | 0 | 0.7 | 0 | 0.75 | 0 | |
Average receivables | 11.24B | 11.94B | 11.94B | 12.78B | 12.78B | |
Average payables | 10.6B | 9.58B | 9.58B | 10.44B | 10.44B | |
Average inventory | 2.18B | 1.95B | 1.95B | 2.12B | 2.12B | |
Days sales outstanding | 0 | 49.95 | 0 | 47.45 | 0 | |
Days payables outstanding | 0 | 77.17 | 0 | 76.44 | 0 | |
Days of inventory on hand | 0 | 15.72 | 0 | 15.5 | 0 | |
Receivables turnover | 0 | 1.8 | 0 | 1.9 | 0 | |
Payables turnover | 0 | 1.17 | 0 | 1.18 | 0 | |
Inventory turnover | 0 | 5.73 | 0 | 5.81 | 0 | |
ROE | 0 | 0.02 | 0 | 0.04 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
APOLLOHOSP.NS Frequently Asked Questions
What is Apollo Hospitals Enterprise Limited stock symbol ?
Apollo Hospitals Enterprise Limited is a IN stock and trading under the symbol APOLLOHOSP.NS
What is Apollo Hospitals Enterprise Limited stock quote today ?
Apollo Hospitals Enterprise Limited stock price is $6354.95 today.
Is Apollo Hospitals Enterprise Limited stock public?
Yes, Apollo Hospitals Enterprise Limited is a publicly traded company.